Targeted next-generation sequencing

DIAGNOSTIC_TEST2 trials

Sponsors

University of California, San Francisco, Capital Medical University

Conditions

Community Acquired Pneumonia (CAP)Cost-Benefit AnalysisDrug-resistant TuberculosisHIV Coinfection

Unknown Phase

Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis

RecruitingNCT05553236

University of California, San FranciscoCost-Benefit Analysis, Drug-resistant Tuberculosis, HIV Coinfection

Start: 2024-08-01End: 2027-01-01Target: 2500Updated: 2026-01-26

Effect of tNGS on CAP Patients With Initial Treatment Failure

Not yet recruitingNCT07472114

Capital Medical UniversityCommunity Acquired Pneumonia (CAP)

Start: 2026-04-10End: 2028-02-28Target: 524Updated: 2026-03-16